Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool aims to curb opioid overprescribing after surgery

NCT ID NCT07510373

Knowledge-focused Sponsor: Montefiore Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a tool called DOTS that helps doctors create a personalized plan to reduce opioid painkillers after orthopedic surgery. The tool is built into the hospital's computer system and includes a taper schedule, a patient handout, and phone support after discharge. Researchers will compare patients whose doctors used DOTS to those who received usual care, looking at how many opioids are prescribed and how well patients manage pain and recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Discharge Opioid Taper Support (DOTS) tool
What this could lead to
If successful, this could provide a simple, scalable way to reduce unnecessary opioid prescriptions after surgery, lowering the risk of long-term opioid use.
What could go wrong
This is a small, early-stage trial with only 42 providers, so results may not apply broadly. The intervention relies on doctors following recommendations, which may not always happen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Aim 1): * Age ≥ 18 years * Any orthopedic surgery during hospitalization * No pre-operative opioid use (no opioids in EHR in past 1 month) Exclusion Criteria (Aim 1): * Opioid Use Disorder \[by International Classification of Diseases, 10th revision (ICD-10), in past 6 months} * Cancer (by ICD-10, in past 6 months) * Receiving hospice care (by ICD-10, in past 6 months) Inclusion Criteria (Aim 2): * Meets criteria for inclusion in Aim 1 Exclusion Criteria (Aim 2): * Not fluent in English * Do not manage their own medications * Unable to provide consent over the phone * Orthopedic surgery due to cancer-related bone disease * No pre-operative opioid use (no opioids per New York state prescription drug monitoring program in past 1 month)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid tapering are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid tapering

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Montefiore Wakefield Campus

    RECRUITING

    The Bronx, New York, 10466, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.